232 related articles for article (PubMed ID: 6942181)
1. In vivo antigenic modification of tumor cells. I. Introduction of murine leukemia virus antigens on non-virus-producing murine sarcomas.
Iglehart JD; Ward EC; Thiel K; Huper G; Geier SS; Bolognesi DP
J Natl Cancer Inst; 1981 Jul; 67(1):107-15. PubMed ID: 6942181
[TBL] [Abstract][Full Text] [Related]
2. In vivo antigenic modification of tumor cells. II. Distribution of virus in sarcoma-bearing mice.
Iglehart JD; Ward EC; Huper G; Thiel K; Bolognesi DP
J Natl Cancer Inst; 1981 Jul; 67(1):117-22. PubMed ID: 6942182
[TBL] [Abstract][Full Text] [Related]
3. In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus.
Iglehart JD; Weinhold KJ; Huper G; Thiel K; Bolognesi DP
J Natl Cancer Inst; 1981 Jul; 67(1):123-30. PubMed ID: 6265678
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of a murine leukemia virus-infected, chemically induced murine sarcoma with antiviral antibodies.
Ward EC; Iglehart JD; Weinhold KJ; Bolognesi DP
J Natl Cancer Inst; 1982 Aug; 69(2):509-15. PubMed ID: 6955550
[TBL] [Abstract][Full Text] [Related]
5. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P
Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
[TBL] [Abstract][Full Text] [Related]
6. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
Basombrío MA; Mayer AM; Pasqualini CD
Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
[TBL] [Abstract][Full Text] [Related]
7. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens.
Flyer DC; Burakoff SJ; Faller DV
J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152
[TBL] [Abstract][Full Text] [Related]
8. Immunity to virus-free syngeneic tumor cell transplantation in the BALB/c mouse after immunization with homologous tumor cells infected with type C virus.
Al-Ghazzouli IK; Donahoe RM; Huang KY; Sass B; Peters RL; Kelloff GJ
J Immunol; 1976 Dec; 117(6):2239-48. PubMed ID: 186539
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of murine leukemia. V. Protection against Friend leukemia virus-induced immune complex glomerulonephritis by passive serum therapy.
Sanfilippo F; Genovesi EV; Collins JJ
J Natl Cancer Inst; 1981 Sep; 67(3):703-17. PubMed ID: 6456369
[TBL] [Abstract][Full Text] [Related]
10. Detection of the major glycoproteins of Friend leukemia virus (gp71) and the murine mammary tumor virus (gp52) on the surface of mouse cells.
Holder WD; Peer GW; Bolognesi DP; Wells SA
Cancer Res; 1976 Sep; 36(9 pt.1):3217-24. PubMed ID: 184944
[TBL] [Abstract][Full Text] [Related]
11. Cell surface antigens of chemically induced fibrosarcomas: detection by a monoclonal antibody of a tumor-restricted Mr 12,000 protein gag antigen encoded by a dual-tropic murine leukemia virus.
Carbone G; Pierotti MA; Boiocchi M; De Leo AB; Ballinari D; Radice P; Borrello MG; Meseguer A; Cernuschi A; Parmiani G
Cancer Res; 1985 Oct; 45(10):4980-5. PubMed ID: 2992769
[TBL] [Abstract][Full Text] [Related]
12. Immunofluorescent analysis of expression of the RNA tumor virus major glycoprotein, gp71, on surfaces of virus-producing murine and other mammalian species cell lines.
Cloyd MW; Bolognesi DP; Bigner DD
Cancer Res; 1977 Mar; 37(3):922-30. PubMed ID: 65219
[TBL] [Abstract][Full Text] [Related]
13. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
[TBL] [Abstract][Full Text] [Related]
14. Alteration of immunogenicity of xenogenized tumor cells in syngeneic rats by the immune responses to virus-associated antigens produced on immunizing cells.
Hosokawa M; Okayasu T; Ikeda K; Katoh H; Suzuki Y; Kobayashi H
Cancer Res; 1983 May; 43(5):2301-5. PubMed ID: 6831454
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to murine leukemia virus gp70 and p15(E) in sera of BALB/c mice immunized with syngeneic chemically induced sarcomas.
Klitzman JM; Brown JP; Hellström KE; Hellström I
J Immunol; 1980 Jun; 124(6):2552-6. PubMed ID: 6246166
[TBL] [Abstract][Full Text] [Related]
16. Expression of murine leukemia virus structural antigens on the surface of chemically induced murine sarcomas.
Grant JP; Bigner DD; Fischinger PJ; Bolognesi DP
Proc Natl Acad Sci U S A; 1974 Dec; 71(12):5037-41. PubMed ID: 4373739
[TBL] [Abstract][Full Text] [Related]
17. In vitro growth inhibition of murine leukemia cells by antibody specific for the major envelope glycoprotein (gp71) of Friend leukemia virus.
Genovesi EV; Collins JJ
J Cell Physiol; 1983 Nov; 117(2):215-29. PubMed ID: 6630299
[TBL] [Abstract][Full Text] [Related]
18. Infectivity of Friend murine leukemia virus for hamster cells.
Ishimoto A
J Natl Cancer Inst; 1985 Apr; 74(4):905-8. PubMed ID: 3857383
[TBL] [Abstract][Full Text] [Related]
19. RNA tumor-virus antigen expression in chemically induced tumors. Virus-genome-specified common antigens detected by complement fixation in mouse tumors induced by 3-methylcholanthrene.
Whitmire CE; Salerno RA; Rabstein LS; Huebner RJ; Turner HC
J Natl Cancer Inst; 1971 Dec; 47(6):1255-65. PubMed ID: 4330465
[No Abstract] [Full Text] [Related]
20. Murine in vitro antigenic modification of tumor cells: effect on susceptibility to natural cell-mediated cytotoxicity.
Langweiler M; Weinhold KJ; Matthews TJ; Bolognesi DP
J Natl Cancer Inst; 1985 Mar; 74(3):699-704. PubMed ID: 2983140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
